Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $11.90 in the prior trading day, Roivant Sciences Ltd (NASDAQ: ROIV) closed at $11.69, down -1.76%. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 20.03 million shares were traded. ROIV stock price reached its highest trading level at $11.89 during the session, while it also had its lowest trading level at $11.45.
Ratios:
Our goal is to gain a better understanding of ROIV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.75 and its Current Ratio is at 27.91. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On January 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $14.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 23 ’24 when Gline Matthew sold 1,983,257 shares for $11.79 per share. The transaction valued at 23,382,600 led to the insider holds 17,870,543 shares of the business.
Kumar Rakhi sold 250,000 shares of ROIV for $2,972,500 on Sep 23 ’24. The Chief Accounting Officer now owns 209,322 shares after completing the transaction at $11.89 per share. On Sep 24 ’24, another insider, DANIEL GOLD &LAURA GOLD JT TEN, who serves as the Director of the company, bought 1,565,670 shares for $11.62 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 8645011456 and an Enterprise Value of 3805531136. As of this moment, Roivant’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 54.61 while its Price-to-Book (P/B) ratio in mrq is 1.59. Its current Enterprise Value per Revenue stands at 24.04 whereas that against EBITDA is -3.743.
Stock Price History:
Over the past 52 weeks, ROIV has reached a high of $13.24, while it has fallen to a 52-week low of $8.24. The 50-Day Moving Average of the stock is 2.06%, while the 200-Day Moving Average is calculated to be 6.26%.
Shares Statistics:
The stock has traded on average 5.89M shares per day over the past 3-months and 13036950 shares per day over the last 10 days, according to various share statistics. A total of 806.68M shares are outstanding, with a floating share count of 372.19M. Insiders hold about 49.67% of the company’s shares, while institutions hold 62.33% stake in the company. Shares short for ROIV as of 1724976000 were 38224998 with a Short Ratio of 6.48, compared to 1722384000 on 41598603. Therefore, it implies a Short% of Shares Outstanding of 38224998 and a Short% of Float of 6.8500000000000005.
